Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis
Arq. neuropsiquiatr; 76 (9), 2018
ABSTRACT Treatment options for multiple sclerosis (MS) have changed over the last few years, bringing about a new category of drugs with more efficient profiles. However, these drugs have come with a whole new profile of potential adverse events that neurologists have to learn well and quickly. One of th...
Anticuerpos Antivirales/sangre, Brasil/epidemiología, Ensayo de Inmunoadsorción Enzimática, Virus JC/inmunología, Leucoencefalopatía Multifocal Progresiva/sangre, Leucoencefalopatía Multifocal Progresiva/inmunología, Esclerosis Múltiple/sangre, Esclerosis Múltiple/tratamiento farmacológico, Esclerosis Múltiple/virología, Natalizumab/efectos adversos, Infecciones por Polyomavirus/epidemiología, Infecciones por Polyomavirus/inmunología, Prevalencia, Seroconversión, Factores Sexuales